RXMD will start hitting more radars as end of year approaches. Here are some highlights from the year to get you started....
1/5/15
Prescriptions filled for the most recent month rose 35% to over 14,000
4/15/15
Progressive Care reported a net revenue increase of 20.74% for the year ended December 31, 2014 as compared to year ended December 31, 2013 , from approximately 9.33 million to approximately $11.27 million . Prescription counts for the year were over 140,000, a 33% increase over 2013 totals
5/21/15
"This year we are on pace to do over $1 million in revenues per month. As the year progresses we expect to accelerate our growth as our marketing efforts yield more results. The company is close to reaching operating profitability and has reduced its debt by over $0.5 million . The short and long term stability of the company has greatly improved, and we believe our shareholders will see the benefits from these results,"
6/25/15
April through May 2015 has provided the company with its strongest prescription revenues to date. With an average of 13,800 prescriptions filled per month, of which approximately 45% are newly authorized prescriptions, PharmCo reached over $2.3 million in revenues for the 2 month period. In May alone, PharmCo achieved $1.4 million in revenues. With only a 28% increase in filled prescriptions over the same period last year, the Company grew revenues by over 30%.
7/9/15
June 2015 marked the strongest pharmacy sales month in company history. Prescriptions filled during the month were over 15,000, a 41% increase over the same month last year and a nearly 10% increase over the all-time record set in December 2014 . Pharmacy revenues for the month amounted to approximately $1.1 million .
7/20/15
announces 340B contract with Empower "U", 340B contracts allow eligible organizations and their contracted pharmacies to purchase medications at a discounted rate for the public good. The national 340B market in the US is estimated to grow to $13.4 billion by 2016. While this only accounts for 2% of all national drug purchases, 340B purchases could amount to more than 25% of the drug purchases made by hospitals and eligible organizations. As the contracted 340B ship-to pharmacy, PharmCo will provide specialty pharmaceuticals to the current health center patients of Empower "U" as well as patients of any future health centers of the organization.
8/6/15
During the three months ended June 30, 2015 , prescriptions counts reached a record high of approximately 43,000 fills. This represents an 11% increase over the first quarter of the year where approximately 39,000 prescriptions were filled. This resulted in a 5.3% increase in revenues for the second quarter of the year.
For the six months ended June 30, 2015 the company achieved its first operating profit since 2010.
8/19/15
July 2015 marked the highest number of prescription filled in a single month since inception of the company. The pharmacy filled over 16,000 prescriptions during the month resulting in approximately $1 million in revenues. This is a 30% increase over the same month last year. Prescriptions filled in July were also 28% higher than the beginning of the year and 5% over last month, which was another record breaking month for the Company. At the outset of the year, PharmCo set a goal of reaching 20,000 prescriptions filled per month. As of the end of July, the Company is half way and remains on pace toward reaching that goal.
9/10/15
The pharmacy filled over 16,500 prescriptions during the month resulting has become one of the preferred pharmacies for managed care organizations leading many providers to recommend PharmCo to its patients for prescription services.in approximately $1.17 million in revenues. This is a 32% increase over the same month last year and the third consecutive month of record prescription sales in 2015.
9/16/15
To date, the Company has issued 163,139,000 shares of its common stock pursuant to the ongoing 3(a)(10) transaction. These shares have generated approximately $1.34 million in available funds for payment to the Company's creditors of which $1.28 million has already been allocated to such creditors. Approximately $585,000 of eligible debt remains for repayment under the transaction.
10/13/15
The pharmacy filled over 17,000 prescriptions during the month, which is a 28% increase over the same month last year and 3.4% higher than last month. Through the third quarter of this year, PharmCo filled over 50,000 prescriptions marking the best sales quarter for the company to date.
Revenues for the quarter also were the highest since the company's inception. In the third quarter of 2015, the company posted a 14% increase over the same quarter last year at approximately $3.3 million. Through the first nine months of this year the company reached nearly $10 million in revenues, achieved positive cash flow and operating profitability.
"This year we have been able to truly capitalize on PharmCo's status as an industry leader in providing unmatched products and services. Our marketing efforts to healthcare institutions has proved fruitful in advancing the company's financial position as well cementing PharmCo as a preferred pharmacy for insurance carriers. As we enter our busiest quarter, we are excited to grow our operation and expand on our success," stated Shital Parikh Mars, COO.
